Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Industry News

Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases

May 16, 2019

News Industry News

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

February 26, 2018

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

May 02, 2017

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

News Industry News

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

October 31, 2016

News Industry News

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

October 30, 2016

News Industry News

Study Finds Ridaforolimus-Eluting Stent is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes

October 30, 2016

News Industry News

Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent

May 17, 2016

News Industry News

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

February 28, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

News Industry News

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

October 12, 2015

News Industry News

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

October 12, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Industry News

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

September 23, 2015

News Industry News

Medtronic to Initiate Clinical Study of Drug-Filled Stent Following Successful Preclinical Results

March 14, 2015

News Industry News

Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

March 12, 2015

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

November 02, 2014

Advertisement

Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

Study Finds Ridaforolimus-Eluting Stent is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes

Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

Medtronic to Initiate Clinical Study of Drug-Filled Stent Following Successful Preclinical Results

Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content